|

EP31670 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NEO2734

Pipeline

Phase 1: 1

Top Sponsors

  • Epigenetix, Inc.1

Indications

  • Castrate Resistant Prostate Cancer1
  • Myelofibrosis1
  • Chronic Myelomonocytic Leukemia1
  • NUT Carcinoma1
  • Cancer1

Phoenix, Arizona1 trial

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Mayo Clinic Arizona

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.